Barclays Boosts Pacira BioSciences (NASDAQ:PCRX) Price Target to $24.00
Pacira BioSciences (NASDAQ:PCRX – Free Report) had its price objective raised by Barclays from $17.00 to $24.00 in a research report sent to investors on Friday morning,Benzinga reports. They currently have an overweight rating on the stock. Other equities analysts have also issued research reports about the stock. HC Wainwright raised their price objective on […]
Pacira BioSciences (NASDAQ:PCRX – Free Report) had its price objective raised by Barclays from $17.00 to $24.00 in a research report sent to investors on Friday morning,Benzinga reports. They currently have an overweight rating on the stock. Other equities analysts have also issued research reports about the stock. HC Wainwright raised their price objective on […]
